Policy Notices

• Notice of Requirement for Electronic Submission of all Administrative Supplements
  (NOT-OD-20-128)
  National Institutes of Health
  

• Public Comments on the Implementation of the Updated AVMA Guidelines for the Euthanasia of Animals: 2020 Edition
  (NOT-OD-20-132)
  National Institutes of Health
  

General Notices

• Notice of Pre-Application Webinar for PAR-20-017 "Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
  (NOT-GM-20-041)
  National Institute of General Medical Sciences
  

• Findings of research misconduct
  (NOT-OD-20-139)
  National Institutes of Health
  

• Request for Information (RFI): Inviting Input on NIDAs Strategic Plan for 2021-2025
  (NOT-DA-20-059)
  National Institute on Drug Abuse
  

Notice of Changes to Funding Opportunities

• Notice to Extend the Response Date for NOT-AR-20-009 "Request for Information (RFI): Input to Advance Artificial Intelligence (AI)-ready Data Generation and Scalable Computational Approaches in NIAMS Research"
  (NOT-AR-20-021)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of NCI's Participation in PA-20-025, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
  (NOT-CA-20-078)
  National Cancer Institute
  

• Notice of NCI's Participation in PA-20-047, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
  (NOT-CA-20-079)
  National Cancer Institute
  

• Notice of Correction to Expiration Date for PAR-20-043, "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)"
  (NOT-CA-20-081)
  National Cancer Institute
  

• Notice of Early Expiration of PAR-18-735 (Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) and PAR-18-736 (Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
  (NOT-HG-20-051)
  National Human Genome Research Institute
  

• Notice of Change to Key Dates for PAR-18-617 "NINDS Exploratory Clinical Trials for Small Business (R42 Clinical Trial Required)"
  (NOT-NS-20-078)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Key Dates for PAR-18-618 "NINDS Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)"
  (NOT-NS-20-079)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction to NOT-OD-20-119, NOT-OD-20-120, NOT-OD-20-121 Eligibility Section
  (NOT-OD-20-138)
  National Institutes of Health
  

• Notice of Correction to NOT-OD-20-120 Eligibility Section for Budget Request Information
  (NOT-OD-20-141)
  National Institutes of Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)
  (NOT-EY-20-011)
  National Eye Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide RPG (R01 Clinical Trial Optional)
  (NOT-MH-20-068)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional)
  (NOT-MH-20-069)
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders
  (NOT-DA-20-058)
  National Institute on Drug Abuse
  

• Notice of Special Interest: Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01, R21)
  (NOT-HD-20-019)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Understanding Sudden Death in the Young Through Research
  (NOT-HL-20-787)
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
  (PA-20-245)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
  (PA-20-246)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
  (PA-20-247)
  National Institutes of Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
  (PA-20-248)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
  
  

• NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
  (PAR-20-249)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 1, 2021, August 2, 2021, November 15, 2021, March 1, 2022, August 2, 2022, November 15, 2022, March 1, 2023, August 2, 2023, November 15, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
  (PAR-20-250)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is September 25, 2020.
  
  

• Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
  (RFA-AI-20-043)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): November 19, 2020
  
  

• Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)
  (RFA-CA-20-040)
  National Cancer Institute
  National Institute on Aging
  Application Receipt Date(s): October 27, 2020; February 17, 2021
  
  

• PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)
  (RFA-DA-21-024)
  National Institute on Drug Abuse
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): November 12, 2020 No late application will be accepted for this Funding Opportunity Announcement.
  
  

• Biomarkers of Dietary Intake and Exposure (U2C Clinical Trial Required)
  (RFA-DK-20-005)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 21, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Biomarkers of Dietary Intake and Exposure Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-DK-20-007)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 21, 2020
  
  

• Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)
  (RFA-DK-20-016)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 10, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on thisdate.
  
  

• BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed)
  (RFA-EB-20-001)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): September 3, 2020 and September 3, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (RFA-EB-20-002)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): September 14, 2020
  
  

• Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed
  (RFA-FD-21-002)
  Food and Drug Administration
  Application Receipt Date(s): October 13, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
  (RFA-HD-21-020)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 10, 2020, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement
  
  

• Network of the National Library of Medicine Evaluation Center (U24) (Clinical Trial Not Allowed)
  (RFA-LM-20-002)
  National Library of Medicine
  Application Receipt Date(s): September 28, 2020